Evidence map›Paper›PMID 20881000›Full record

ArticleCarcinogenesis2010

Hypoxia and nickel inhibit histone demethylase JMJD1A and repress Spry2 expression in human bronchial epithelial BEAS-2B cells.

Haobin Chen, Thomas Kluz, Ronghe Zhang, Max Costa

Open access · bronzeAbstract read
In one paragraph

Article in Carcinogenesis, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 94 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Update of the risk assessment of nickel in food and drinking water.EFSA journal. European Food Safety Authority · 2020
    Article
  13. Review
  14. Article
  15. Article
  16. Metals and Mechanisms of Carcinogenesis.Annual review of pharmacology and toxicology · 2019
    Review
  17. Small molecule KDM4s inhibitors as anti-cancer agents.Journal of enzyme inhibition and medicinal chemistry · 2018
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Haobin ChenDepartment of Environmental Medicine, New York University of School of Medicine, 550 First Avenue, New York, NY 10016, USA. haobin.chen@nyumc.org
Thomas Kluz
Ronghe Zhang
Max Costa
New York University · US

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
RESEARCH IN ENVIRONMENTAL HEALTH SCIENCES (CENTER GRANT)P30ES000260 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI COSTA, MAX · 1985 to 2020
$26.1M
Water/sediment &model &criteria for arsenic &chromeP42ES010344 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI COSTA, MAX · 2000 to 2010
$15.0M
Carcinogenesis of Nickel and Epigenetic ControlR01ES005512 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI COSTA, MAX · 1991 to 2011
$5.8M
Hypoxia Signaling, Chromatin Remodeling and Nickel CarcinogenesisR01ES014454 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI COSTA, MAX · 2006 to 2009
$1.7M
NCI NIH HHS CA16087NCI NIH HHS P30 CA016087NIEHS NIH HHS ES000260NIEHS NIH HHS ES005512NIEHS NIH HHS ES010344NIEHS NIH HHS ES014454NIEHS NIH HHS ES10344NIEHS NIH HHS P30 ES000260NIEHS NIH HHS P42 ES010344NIEHS NIH HHS R01 ES005512NIEHS NIH HHS R01 ES014454
6 · The paper itself

Abstract

Epigenetic silencing of tumor suppressor genes commonly occurs in human cancers via increasing DNA methylation and repressive histone modifications at gene promoters. However, little is known about how pathogenic environmental factors contribute to cancer development by affecting epigenetic regulatory mechanisms. Previously, we reported that both hypoxia and nickel (an environmental carcinogen) increased global histone H3 lysine 9 methylation in cells through inhibiting a novel class of iron- and α-ketoglutarate-dependent histone demethylases. Here, we investigated whether inhibition of histone demethylase JMJD1A by hypoxia and nickel could lead to repression/silencing of JMJD1A-targeted gene(s). By using Affymetrix GeneChip and ChIP-on-chip technologies, we identified Spry2 gene, a key regulator of receptor tyrosine kinase/extracellular signal-regulated kinase (ERK) signaling, as one of the JMJD1A-targeted genes in human bronchial epithelial BEAS-2B cells. Both hypoxia and nickel exposure increased the level of H3K9me2 at the Spry2 promoter by inhibiting JMJD1A, which probably led to a decreased expression of Spry2 in BEAS-2B cells. Repression of Spry2 potentiated the nickel-induced ERK phosphorylation, and forced expression of Spry2 in BEAS-2B cells decreased the nickel-induced ERK phosphorylation and significantly suppressed nickel-induced anchorage-independent growth. Taken together, our results suggest that histone demethylases could be targets of environmental carcinogens and their inhibition may lead to altered gene expression and eventually carcinogenesis.

Indexed as

Cell HypoxiaAnimalsBronchiBronchial NeoplasmsCarcinogens, EnvironmentalCell ProliferationCells, CulturedDown-RegulationExtracellular Signal-Regulated MAP KinasesHumansHypoxia-Inducible Factor 1, alpha SubunitIntracellular Signaling Peptides and ProteinsJumonji Domain-Containing Histone DemethylasesMembrane ProteinsMiceNickelCarcinogens, EnvironmentalExtracellular Signal-Regulated MAP KinasesHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitIntracellular Signaling Peptides and ProteinsJumonji Domain-Containing Histone DemethylasesKDM3A protein, humanMembrane ProteinsNickelSPRY2 protein, human

Identifiers

PMID20881000
PMCPMC2994281
OpenAlexW2138963395

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.